ClassID:

94426

C07D233/76 - CPC Classification

Classification description:

Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms; Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom

Sub-classes:
Recent Application in this class:
#1
20250353819
2025-11-20

ARYL HYDANTOIN COMPOUNDS AND METHODS OF USE

#2
20240374773
2024-11-14

COMPOSITION FOR THE PREVENTION AND ELIMINATION OF ODORS

#3
20220380325
2022-12-01

ANDROGEN RECEPTOR MODULATORS AND METHODS FOR THEIR USE

#4
20220048855
2022-02-17

Method for producing methionine

#5
20210275704
2021-09-09

Method for manufacturing a medium for purifying fluids containing toxic compounds

#6
20200247763
2020-08-06

Androgen receptor modulators and methods for their use

#7
20200163964
2020-05-28

IMIDAZOLIDINEDIONE DERIVATIVES

#8
20200148648
2020-05-14

Hydantoins that modulate BACE-mediated app processing

#9
20200085987
2020-03-19

N-halamine composition for the prevention and elimination of odors

#10
20200017449
2020-01-16

HYDANTOINS THAT MODULATE BACE-MEDIATED APP PROCESSING

#11
20190330210
2019-10-31

Hydantoin containing deoxyuridine triphosphatase inhibitors

#12
20190231916
2019-08-01

Halogenated heterocyclic N-halamine coated garbage bags

#13
20190231915
2019-08-01

Method of manufacturing particulate halogenated heterocyclic N-halamine compositions for the prevention and elimination of odors

#14
20180338974
2018-11-29

Imidazolidinedione derivatives

#15
20180297957
2018-10-18

Compounds, polymers and coating formulations that comprise at least one N-halamine precursor, a cationic center and a coating incorporation group

#16
20180200399
2018-07-19

Halogenated heterocyclic N-halamine composition for the prevention and elimination of odors

#17
20180194737
2018-07-12

Hydantoins that modulate BACE-mediated APP processing

#18
20180127368
2018-05-10

Tricyclic sulfones as ROR gamma modulators

#19
20180021336
2018-01-25

Imidazolidinedione derivatives

#20
20170107203
2017-04-20

HETEROCYCLIC INHIBITORS OF THE SODIUM CHANNEL

#21
20170065585
2017-03-09

Imidazolidinedione derivatives

#22
20160242083
2016-08-18

Method, device, and system for radio resource management measurement

#23
20160159746
2016-06-09

Hydantoins that modulate BACE-mediated APP processing

#24
20160016939
2016-01-21

Heterocyclic inhibitors of the sodium channel

#25
20160009658
2016-01-14

Hydantoins that modulate bace-mediated app processing

#26
20150252006
2015-09-10

Inhibitors of peptidyl arginine deiminase (PAD) enzymes and uses thereof

#27
20150218107
2015-08-06

Aggrecanase inhibitors

#28
20150175535
2015-06-25

Method of production of a methionine salt

#29
20150018377
2015-01-15

Imidazolidinedione derivatives

#30
20140371283
2014-12-18

HYDANTOINS THAT MODULATE BACE-MEDIATED APP PROCESSING

#31
20140286952
2014-09-25

Inhibitors of metastasis, methods of generating such inhibitors and their therapeutic applications

#32
20130261331
2013-10-03

Process for producing optically active α-methylcysteine derivative

#33
20130231501
2013-09-05

Method of production of a methionine salt

#34
20130022644
2013-01-24

NOVEL N-PHENYLACETAMIDE DERIVATIVES, WHICH INHIBIT THE ENZYME SOAT-1, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM

#35
20120289526
2012-11-15

Imidazolidinedione derivatives

#36
20120208797
2012-08-16

Pyrimidone derivatives

#37
20120184580
2012-07-19

Substituted di-arylhydantoin and di-arylthiohydantoin compounds and methods of use thereof

#38
20120183494
2012-07-19

N-halamine acrylamide monomers and copolymers thereof for biocidal coatings

#39
20120172406
2012-07-05

Androgen receptor antagonists and uses thereof

#40
20120083514
2012-04-05

Imidazolidine-2,4-dione derivatives, and use thereof as a cancer drug

#41
20120021017
2012-01-26

N-phenylacetamide derivatives, which inhibit the enzyme SOAT-1, and pharmaceutical and cosmetic compositions containing them

#42
20120015994
2012-01-19

(2,5-dioxoimidazolidin-i-yl)-n-hydroxy-acetamides as metalloproteinase inhibitors

#43
20110319659
2011-12-29

METHOD FOR PRODUCING METHIONINE

#44
20110263664
2011-10-27

Inhibitors of PIM-1 Protein Kinases, Compositions and Methods for Treating Prostate Cancer

#45
20110230479
2011-09-22

NEUROTROPHIN MIMETICS AND USES THEREOF

#46
20110230452
2011-09-22

Compounds and methods for the treatment of pain and other diseases

#47
20110003853
2011-01-06

Metalloproteinase Inhibitors

#48
20100298381
2010-11-25

GAMMA SECRETASE MODULATORS

#49
20100273849
2010-10-28

Metalloproteinase inhibitors

#50
20100197934
2010-08-05

PROCESS FOR PRODUCING OPTICALLY ACTIVE ALPHA-METHYLCYSTEINE DERIVATIVE

#51
20100174092
2010-07-08

5 substituted hydantoins

#52
20100063119
2010-03-11

Substituted carbinol compound

#53
20100063118
2010-03-11

Hydantoins Having RNase Modulatory Activity

#54
20090325961
2009-12-31

Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof

#55
20090215846
2009-08-27

(2,5-dioxoimidazolidin-1-yl)-N-hydroxy-acetamides as metalloproteinase inhibitors

#56
20090214697
2009-08-27

Derivatives of seleno-amino acids

#57
20090099186
2009-04-16

INHIBITORS OF VIRAL REPLICATION

#58
20090054659
2009-02-26

Process to prepare sulfonyl chloride derivatives

#59
20090030056
2009-01-29

Sodium channel blockers

#60
20080311277
2008-12-18

DERIVATIVES OF SELENO-AMINO ACIDS

#61
20080306065
2008-12-11

Metalloproteinase inhibitors

#62
20080262045
2008-10-23

Metalloproteinase inhibitors

#63
20080241896
2008-10-02

PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE HYDROXYMETHYL-SUBSTITUTED PHENYLALANINE

#64
20080226618
2008-09-18

Hydantoin derivatives useful as antibacterial agents

#65
20080171882
2008-07-17

Metalloproteinase inhibitors

#66
20080081910
2008-04-03

CYCLOALKYLFUSED INDOLE, BENZOTHIOPHENE, BENZOFURAN AND INDENE DERIVATIVES

#67
20080058397
2008-03-06

Therapeutic substituted hydantoins and related compounds

#68
20070249697
2007-10-25

Imidazolidine derivatives

#69
20070197617
2007-08-23

Substituted hydantoins

#70
20070185056
2007-08-09

Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof

#71
20070155810
2007-07-05

Peptide deformylase inhibitors

#72
20070142333
2007-06-21

CYCLOALKYL INHIBITORS OF POTASSIUM CHANNEL FUNCTION

#73
20070135505
2007-06-14

Aralkyl ester soft drugs

#74
20070015829
2007-01-18

Derivatives of seleno-amino acids

#75
20070010689
2007-01-11

Optically active 3,3'-dithiobis(2-amino-2methylpropionic acid) derivative and process for producing optically active 2-amino-3-mercapto-2-methylpropionic acid derivative

#76
20060223784
2006-10-05

Method and compositions for temporarily incapacitating subjects

#77
20060211712
2006-09-21

Bicyclic anilide spirohydantoin CGRP receptor antagonists

#78
20060205759
2006-09-14

Cycloalkyfused indole, benzothiophene, benzofuran and idene derivatives

#79
20060166990
2006-07-27

Aminobenzophenone compounds

#80
20060142363
2006-06-29

Imidazolidinedione analogs useful as anticoagulants and antithrombotics

#81
20060111339
2006-05-25

Oral general anesthetics and metabolitically resistant anticonvulsants

#82
20060105435
2006-05-18

Process for producing optically active alpha-methylcysteine derivative

#83
20060063818
2006-03-23

Hydantoin derivatives and deren verwendung als tace inhibitoren

#84
20060051846
2006-03-09

Process for producing l-alpha-methylcysteine derivative

#85
20060019994
2006-01-26

I-sulphonlyl piperidine derivatives

#86
20060004103
2006-01-05

Method for producing lysine derivative

#87
20050261273
2005-11-24

Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors

#88
20050256176
2005-11-17

Sulphonamide derivatives and their use as tace inhibitors

#89
20050234106
2005-10-20

Cycloalkyl inhibitors of potassium channel function

#90
20050228033
2005-10-13

Sodium channel blockers

#91
20050203156
2005-09-15

Hydantoins having RNase modulatory activity

#92
20050171096
2005-08-04

Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)

#93
20050165106
2005-07-28

Amidino compounds useful as nitric oxide synthase inhibitors

#94
20050153968
2005-07-14

Monocyclic -Aryl hydantoin modulators of androgen receptor function

#95
20050124677
2005-06-09

Peptide deformylase inhibitors

#96
20050020652
2005-01-27

Peroxisome proliferator activated receptor agonists

#97
18423201
2024-12-24

4-[4,4-bis(4-chlorophenyl)-2,5-dioxoimidazolidin-1-yl]butanoic acid as an antimicrobial compound

#98
18402989
2024-04-30

Ethyl 3-[4,4-bis(4-chlorophenyl)-2,5-dioxoimidazolidin-1-yl]propanoate as an antimicrobial compound

#99
18402564
2024-12-31

3-[4,4-bis(4-nitrophenyl)-2,5-dioxoimidazolidin-1-yl]propanoic acid as an antimicrobial compound

#100
18402538
2024-12-31

6-[4,4-bis(4-bromophenyl)-2,5-dioxoimidazolidin-1-yl]hexanoic acid as an antimicrobial compound